Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aethlon Medical Inc AEMD

Healthcare Medical Devices
Aethlon Medical, Inc. is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. The Hemopurifier, in pre-clinical studies, has demonstrated the removal of harmful exosomes from biological fluids, utilizing its lectin-based... see more

Recent & Breaking News (NDAQ:AEMD)

Aethlon Medical To Release Quarterly Financial Results and Host Conference Call on February 11, 2019

PR Newswire February 4, 2019

Aethlon Announces Appointment of Timothy Rodell as Interim Chief Executive Officer

PR Newswire December 13, 2018

Aethlon Medical's Cancer Therapy Receives "Breakthrough Device" Designation from the U.S. Food and Drug Administration

PR Newswire November 27, 2018

Aethlon Medical Announces Second Quarter Fiscal Year 2019 Results

PR Newswire November 6, 2018

Aethlon Medical To Release Quarterly Financial Results and Host Conference Call on November 6, 2018

PR Newswire November 1, 2018

Aethlon Medical to Present at the NYC Oncology Conference

PR Newswire October 29, 2018

Aethlon Medical to Present at the 2018 BIO Investor Forum

PR Newswire October 16, 2018

Aethlon Medical Receives National Cancer Institute Award

PR Newswire September 18, 2018

Aethlon Medical Announces First Quarter Fiscal Year 2019 Results

PR Newswire August 8, 2018

Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2019 and Host Conference Call on August 8, 2018

PR Newswire August 2, 2018

Aethlon Medical Announces Issuance of Hemopurifier® Patent To Treat Life-Threatening Viruses

PR Newswire July 23, 2018

Guy Cipriani Joins Aethlon Medical's Board of Directors

PR Newswire June 25, 2018

New Research: Key Drivers of Growth for Nicolet Bankshares, Vitamin Shoppe, Aethlon Medical, Barrett Business Services, Veracyte, and TPG Specialty Lending — Factors of Influence, Major Initiatives and Sustained Production

GlobeNewswire June 21, 2018

Aethlon Medical Announces Fiscal 2018 Results

PR Newswire June 8, 2018

Aethlon Medical To Release 2018 Fiscal Year End Financial Results and Host Conference Call on June 8, 2018

PR Newswire May 31, 2018

Aethlon Medical Announces Pricing of $6 Million Public Offering

PR Newswire October 2, 2017

Aethlon Medical Receives National Cancer Institute Contract Award

PR Newswire September 14, 2017

14 Biggest Mid-Day Gainers For Tuesday

Benzinga.com  September 12, 2017

Mid-Day Market Update: Advaxis Drops Following Q3 Results; Aethlon Medical Shares Climb

Benzinga.com  September 12, 2017

22 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  September 12, 2017